"In considering whether to give emergency-use authorization to the Pfizer-BioNTech vaccine for children under 5 years old, it is imperative that the Food and Drug Administration retains public trust and protects the integrity of the process. Many parents are eager for their children to get this vaccine, but many others might be hesitant. The FDA is taking an unusual route in considering the merits and must not leave any doubts in the air."